RAMP Trial Design

Cross-source consensus on RAMP Trial Design from 1 sources and 5 claims.

1 sources · 5 claims

Comparisons

RAMP is a prospective multicentre randomised controlled trial with 12 months of follow-up. — LED red light for atrophy and microcirculation in pathologic myopia (RAMP): study design and protocol for a multicentre randomised controlled trial
The study plans to enrol 158 adults with pathologic myopia aged 18-55 years. — LED red light for atrophy and microcirculation in pathologic myopia (RAMP): study design and protocol for a multicentre randomised controlled trial
Participants are randomly assigned in a 1:1 ratio to active RLRL or sham control, with 79 participants in each arm. — LED red light for atrophy and microcirculation in pathologic myopia (RAMP): study design and protocol for a multicentre randomised controlled trial
Recruitment began on 31 December 2025 and the full study is expected to end by 30 December 2028. — LED red light for atrophy and microcirculation in pathologic myopia (RAMP): study design and protocol for a multicentre randomised controlled trial
The sham control devices look identical and emit the same 660 nm wavelength at a non-therapeutic power density. — LED red light for atrophy and microcirculation in pathologic myopia (RAMP): study design and protocol for a multicentre randomised controlled trial